By A Mystery Man Writer
ObjectiveA low serum 25-hydroxyvitamin D (25(OH)D) level is relevant to both the occurrence and recurrence of benign paroxysmal positional vertigo (BPPV). Ho
Serum 25-hydroxyvitamin D - List of Frontiers' open access articles
Frontiers Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on 18F-FDG PET
Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age
Investigation of vitamin D status and its correlation with insulin resistance in a Chinese population, Public Health Nutrition
PDF) Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo
Frontiers TGF-β based risk model to predict the prognosis and immune features in glioblastoma
Frontiers Low 25-Hydroxyvitamin D Levels Are Associated With Residual Dizziness After Successful Treatment of Benign Paroxysmal Positional Vertigo
Critical Care Nursing of the Oncology Patient [1 ed.] 9781635930153, 9781635930146
PDF) Age-Related Increases in Benign Paroxysmal Positional Vertigo Are Reversed in Women Taking Estrogen Replacement Therapy: A Population-Based Study in Taiwan
Residual Dizziness in Elderly Patients after Benign Paroxysmal Positional Vertigo
PDF) Age-Related Increases in Benign Paroxysmal Positional Vertigo Are Reversed in Women Taking Estrogen Replacement Therapy: A Population-Based Study in Taiwan
Assessment of residual dizziness after successful canalith repositioning maneuvre in benign paroxysmal positional vertigo patients: a questionnaire-based study
Residual Dizziness in Elderly Patients after Benign Paroxysmal Positional Vertigo
Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age